Insider Trading & Ownership of INTERWEST PARTNERS X LP

Location
San Francisco, CA
Summary
The estimated value of insider holdings of INTERWEST PARTNERS X LP is at least $241,941,494 dollars as of 06 Dec 2021. INTERWEST PARTNERS X LP is the 10%+ Owner of Doximity, Inc. and owns shares of Doximity, Inc. (DOCS) stock worth about $231.9M. INTERWEST PARTNERS X LP is the 10%+ Owner of PMV Pharmaceuticals, Inc. and owns shares of PMV Pharmaceuticals, Inc. (PMVP) stock worth about $10.04M.
Signature
/s/ Karen A. Wilson, Attorney-in Fact for InterWest Partners X, LP
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow INTERWEST PARTNERS X LP and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • INTERWEST PARTNERS X LP has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $241,941,494.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Doximity, Inc. ($231,900,963).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of INTERWEST PARTNERS X LP

DOCS Forms 3/4/5

Doximity, Inc.

Relationship
10%+ Owner
Holdings value
$231,900,963
Past year net change
Change %
Report period
02 Dec 2021

Insider Transactions Reported by INTERWEST PARTNERS X LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .